IP Library Granted Patent US 6,958,231
Granted Patent B2
US 6,958,231 · App. 10/251,078 · Granted Oct 25, 2005

Variants of Erwinia-type creatinase

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,958,231
App. No.
10/251,078
Granted
Oct 25, 2005
Kind
B2
Abstract

The present invention relates to mutated genes encoding variants of an Erwinia -type creatinase (EC 3.5.3.3, alternative name: creatine amidinohydrolase), to the creatinase variants encoded by these genes, and to different applications of these variants of creatinase, particularly to their use for determining the creatinine and/or creatine concentration in a sample.

Claims (9)

1. A variant creatinase having creatinase activity comprising at least one amino acid substitution at a position corresponding to an amino acid position of SEQ ID NO: 2 selected from the group of positions consisting of N130, M203, I278, I304, and F395, wherein the variant creatinase comprises a sequence with 20 or less adding acid substitutions compared to SEQ ID NO:2.

2. The creatinase according to claim 1 wherein at least one substitution is at an amino acid position corresponding to position N130 or I278.

3. The creatinase according to claim 2 , wherein the creatinase is more stable than wild type Erwinia creatinase of SEQ ID NO:2 at 56° C.

4. The creatinase according to claim 1 wherein at least one amino acid substitution is at an amino acid position corresponding to positions I304 or F395.

5. The creatinase according to claim 4 , wherein the creatinase exhibits a lower Km-value in the enzymatic cleavage of creatine than wild-type Erwinia creatinase of SEO ID NO:2.

6. A variant creatinase having creatinase activity comprising at least two amino acid substitutions at positions corresponding to amino acid positions of SEQ ID NO: 2, the positions being selected from the group of positions consisting of N130, M203, I278, I304, and F395, wherein at least one amino acid substitution is at position N130 or I278 and at least one substitution is at position I304 or F395, wherein the variant creatinase comprises a sequence with 20 or less amino acid substitutions compared to SEQ ID NO:2.

7. The creatinase according to claim 6 wherein the creatinase is more stable than wild type Erwinia creatinase of SEQ ID NO:2 at 56° C. and the creatinase exhibits a lower Km-value in the enzymatic cleavage of creatine than wild type Erwinia creatinase of SEQ ID NO:2.

8. A composition comprising the modified creatinase of claim 1 , sarcosine oxidase and reagents for the detection of hydrogen peroxide.

9. A composition comprising the modified creatinase of claim 6 , sarcosine oxidase and reagents for the detection of hydrogen peroxide.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2004
From: ROCHE DIAGNOSTICS CORPORATION
To: ROCHE DIAGNOSTICS OPERATIONS, INC.
Reel/Frame 015215/0061 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 26, 2002
From: ROCHE DIAGNOSTICS GMBH
To: ROCHE DIAGNOSTICS CORPORATION
Reel/Frame 013604/0439 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 26, 2002
From: SHAO, ZHIXIN; SCHMUCK, RAINER; KRATZSCH, PETER; KENKLIES, JANET; WEISSER, HARALD
To: ROCHE DIAGNOSTICS GMBH
Reel/Frame 013604/0867 →